Zoetis Inc. (ZTS) stock
ZTSNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 17/3046% below fair value
$83.48−0.91 (-1.08%)
Close on Nov 17, 2026Market cap $34.50BP/E 13.7Yield 2.43%
Zoetis total debt
Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.
Zoetis's total debt was $9.05B at Jun 30, 2026. For fiscal 2025 it was $9.04B, up 37.6% from the year before. Over ten years it grew 7.3% a year on average. The highest annual figure on record is $9.04B in fiscal 2025.
Annual total debt
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $9.04B | +37.6% |
| FY2024 | Dec 31, 2024 | $6.57B | +0.0% |
| FY2023 | Dec 31, 2023 | $6.57B | -16.9% |
| FY2022 | Dec 31, 2022 | $7.90B | +19.9% |
| FY2021 | Dec 31, 2021 | $6.59B | -8.4% |
| FY2020 | Dec 31, 2020 | $7.20B | +11.7% |
| FY2019 | Dec 31, 2019 | $6.45B | -0.1% |
| FY2018 | Dec 31, 2018 | $6.45B | +30.3% |
| FY2017 | Dec 31, 2017 | $4.95B | +10.9% |
| FY2016 | Dec 31, 2016 | $4.47B | 0.0% |
| FY2015 | Dec 31, 2015 | $4.47B | +23.1% |
| FY2014 | Dec 31, 2014 | $3.63B | -0.7% |
| FY2013 | Dec 31, 2013 | $3.66B | +4909.6% |
| FY2012 | Dec 31, 2012 | $73.00M | – |
Quarterly total debt
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $9.05B | +37.5% |
| Q1 FY2026 | Mar 31, 2026 | $9.05B | +37.5% |
| Q4 FY2025 | Dec 31, 2025 | $9.04B | +37.6% |
| Q3 FY2025 | Sep 30, 2025 | $7.07B | +7.5% |
| Q2 FY2025 | Jun 30, 2025 | $6.58B | +0.3% |
| Q1 FY2025 | Mar 31, 2025 | $6.58B | -0.1% |
| Q4 FY2024 | Dec 31, 2024 | $6.57B | +0.0% |
| Q3 FY2024 | Sep 30, 2024 | $6.57B | +0.3% |
| Q2 FY2024 | Jun 30, 2024 | $6.56B | +0.1% |
| Q1 FY2024 | Mar 31, 2024 | $6.59B | +0.4% |
| Q4 FY2023 | Dec 31, 2023 | $6.57B | -16.9% |
| Q3 FY2023 | Sep 30, 2023 | $6.55B | -0.1% |
| Q2 FY2023 | Jun 30, 2023 | $6.56B | -0.2% |
| Q1 FY2023 | Mar 31, 2023 | $6.56B | -0.2% |
| Q4 FY2022 | Dec 31, 2022 | $7.90B | +19.9% |
| Q3 FY2022 | Sep 30, 2022 | $6.56B | -0.4% |
| Q2 FY2022 | Jun 30, 2022 | $6.57B | -8.7% |
| Q1 FY2022 | Mar 31, 2022 | $6.58B | -8.5% |
| Q4 FY2021 | Dec 31, 2021 | $6.59B | -8.4% |
| Q3 FY2021 | Sep 30, 2021 | $6.59B | -14.3% |
| Q2 FY2021 | Jun 30, 2021 | $7.20B | -6.5% |
| Q1 FY2021 | Mar 31, 2021 | $7.19B | +11.3% |
| Q4 FY2020 | Dec 31, 2020 | $7.20B | +11.7% |
| Q3 FY2020 | Sep 30, 2020 | $7.70B | +19.4% |
| Q2 FY2020 | Jun 30, 2020 | $7.70B | +19.4% |
| Q1 FY2020 | Mar 31, 2020 | $6.46B | +0.3% |
| Q4 FY2019 | Dec 31, 2019 | $6.45B | -0.1% |
| Q3 FY2019 | Sep 30, 2019 | $6.45B | +0.1% |
| Q2 FY2019 | Jun 30, 2019 | $6.45B | +30.1% |
| Q1 FY2019 | Mar 31, 2019 | $6.44B | +30.1% |
| Q4 FY2018 | Dec 31, 2018 | $6.45B | +30.3% |
| Q3 FY2018 | Sep 30, 2018 | $6.44B | +13.0% |
| Q2 FY2018 | Jun 30, 2018 | $4.96B | +8.4% |
| Q1 FY2018 | Mar 31, 2018 | $4.95B | +10.9% |
| Q4 FY2017 | Dec 31, 2017 | $4.95B | +10.9% |
| Q3 FY2017 | Oct 1, 2017 | $5.70B | +27.6% |
| Q2 FY2017 | Jul 2, 2017 | $4.57B | – |
| Q1 FY2017 | Apr 2, 2017 | $4.47B | – |
| Q4 FY2016 | Dec 31, 2016 | $4.47B | – |
| Q3 FY2016 | Oct 2, 2016 | $4.47B | – |
See a number that looks wrong?